Development of a new system for evaluating visual function in diabetic retinopathy using EvokeDx

Development of a new system for evaluating visual function in diabetic retinopathy using EvokeDx - DREX Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040444

Enrollment

100

Registered

2020-05-20

Start date

2020-07-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adults and Diabetic patients who have best-corrected visual acuity better than 0.7 in decimal.

Exclusion criteria

Exclusion criteria: Patients with diabetic macular edema, galucoma, and who had been treated diabetic retinopathy within 12 weeks. If the researchers found the person not suitable for the study, the person will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
Visual function measured by EvokeDx	—

Countries

Japan

Contacts

Public ContactYoko Ozawa

St Luke's International Hospital Department of Ophthalmology

ozaway@luke.ac.jp03-3451-5151

Outcome results